title: Differences in both inositol 1,4,5-trisphosphate mass and inositol 1,4,5-trisphosphate receptors between normal and dystrophic skeletal muscle cell lines.
abstract: Human normal (RCMH) and Duchenne muscular dystrophy (RCDMD) cell lines, as well as newly developed normal and dystrophic murine cell lines, were used for the study of both changes in inositol 1,4,5-trisphosphate (IP3) mass and IP3 binding to receptors. Basal levels of IP3 were increased two- to threefold in dystrophic human and murine cell lines compared to normal cell lines. Potassium depolarization induced a time-dependent IP3 rise in normal human cells and cells of the myogenic mouse cell line (129CB3), which returned to their basal levels after 60 s. However, in the human dystrophic cell line (RCDMD), IP3 levels remained high up to 200 s after potassium depolarization. Expression of IP3 receptors was studied measuring specific binding of 3H-IP3 in the murine cell lines (normal 129CB3 and dystrophic mdx XLT 4-2). All the cell lines bind 3H-IP3 with relatively high affinity (Kd: between 40 and 100 nmol/L). IP3 receptors are concentrated in the nuclear fraction, and their density is significantly higher in dystrophic cells compared to normal. These findings together with high basal levels of IP3 mass suggest a possible role for this system in the deficiency of intracellular calcium regulation in Duchenne muscular dystrophy.
authors.affiliation: Department of Physiology and Biophysics, Faculty of Medicine, University of Chile, Santiago, Chile.
authors.forename: J L
authors.initials: JL
authors.lastname: Liberona
authors.forename: J A
authors.initials: JA
authors.lastname: Powell
authors.forename: S
authors.initials: S
authors.lastname: Shenoi
authors.forename: L
authors.initials: L
authors.lastname: Petherbridge
authors.forename: R
authors.initials: R
authors.lastname: Caviedes
authors.forename: E
authors.initials: E
authors.lastname: Jaimovich
mesh_terms: D000185:Actinin / Q000032:analysis; D000818:Animals; D015220:Calcium Channels / Q000032:analysis* / Q000378:metabolism; D002458:Cell Fractionation; D002460:Cell Line; D016189:Dystrophin / Q000172:deficiency / Q000235:genetics; D004594:Electrophysiology; D006801:Humans; D015544:Inositol 1,4,5-Trisphosphate / Q000032:analysis* / Q000378:metabolism / Q000494:pharmacology; D053496:Inositol 1,4,5-Trisphosphate Receptors; D008564:Membrane Potentials / Q000187:drug effects / Q000502:physiology; D051379:Mice; D008810:Mice, Inbred C57BL; D018101:Mice, Inbred mdx; D018482:Muscle, Skeletal / Q000737:chemistry / Q000166:cytology / Q000378:metabolism*; D009137:Muscular Dystrophy, Animal / Q000378:metabolism*; D011189:Potassium Chloride / Q000494:pharmacology; D011869:Radioligand Assay; D018160:Receptors, Cytoplasmic and Nuclear / Q000819:agonists / Q000032:analysis* / Q000378:metabolism; D012433:Ryanodine / Q000494:pharmacology; D014316:Tritium
chemical_list: D015220:Calcium Channels; D016189:Dystrophin; C506926:ITPR1 protein, human; D053496:Inositol 1,4,5-Trisphosphate Receptors; D018160:Receptors, Cytoplasmic and Nuclear; D014316:Tritium; D000185:Actinin; D012433:Ryanodine; D011189:Potassium Chloride; D015544:Inositol 1,4,5-Trisphosphate